Safety of Recombinant Human Growth Hormone for Malnutritional COPD Patients / 中国药房
China Pharmacy
;
(12)1991.
Artículo
en Chino
| WPRIM
| ID: wpr-531875
ABSTRACT
0.05).In the treat groups seralbumin and plasma osmotic pressure showed significant difference before and after treatment(P0.05).CONCLUSION:
There were some adverse effects in the rhGH treatment for malnutritional COPD patients,but they won't influence the treatment.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Idioma:
Chino
Revista:
China Pharmacy
Año:
1991
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS